Repurposed drugs in combinations exert additive anti-chikungunya virus activity: an in-vitro study.

Chikungunya virus (CHIKV) infection causes chikungunya, a viral disease that currently has no specific antiviral treatment. Several repurposed drug candidates have been investigated for the treatment of the disease. In order to improve the efficacy of the known drugs, combining drugs for treatment is a promising approach.

Corrigendum: Drug repurposing approach against chikungunya virus: an and study.

[This corrects the article DOI: 10.3389/fcimb.2023.

Drug repurposing approach against chikungunya virus: an and study.

The chikungunya virus (CHIKV) is an alphavirus transmitted by . There are no licenced antivirals or vaccines for treatment or prevention. Drug repurposing approach has emerged as a novel concept to find alternative uses of therapeutics to battle pathogens.